The enigmatic role of IL-38 in inflammatory diseases

Lin, 2001, Cloning and characterization of IL-1HY2, a novel interleukin-1 family member, J. Biol. Chem., 276, 20597, 10.1074/jbc.M010095200 Bensen, 2001, Identification of a novel human cytokine gene in the interleukin gene cluster on chromosome 2q12-14, J. Interferon Cytokine Res., 21, 899, 10.1089/107999001753289505 Dinarello, 2010, IL-1 family nomenclature, Nat. Immunol., 11, 973, 10.1038/ni1110-973 Carta, 2013, Different members of the IL-1 family come out in different ways: DAMPs vs. cytokines?, Front. Immunol., 4, 123, 10.3389/fimmu.2013.00123 Takenaka, 2015, IL-38: a new factor in rheumatoid arthritis, Biochem. Biophys. Rep., 4, 386 Palomo, 2015, The interleukin (IL)-1 cytokine family—balance between agonists and antagonists in inflammatory diseases, Cytokine, 76, 25, 10.1016/j.cyto.2015.06.017 Jung, 2010, The interleukin-1 family gene polymorphisms in Korean patients with rheumatoid arthritis, Scand. J. Rheumatol., 39, 190, 10.3109/03009740903447028 Monnet, 2012, Association between the IL-1 family gene cluster and spondyloarthritis, Ann. Rheum. Dis., 71, 885, 10.1136/annrheumdis-2011-200439 Guo, 2010, Association of IL-1 gene complex members with ankylosing spondylitis in Chinese Han population, Int. J. Immunogenet., 37, 33, 10.1111/j.1744-313X.2009.00889.x Chou, 2006, Replication of association of IL1 gene complex members with ankylosing spondylitis in Taiwanese Chinese, Ann. Rheum. Dis., 65, 1106, 10.1136/ard.2005.046847 Lea, 2012, The associations between interleukin-1 polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis, Joint Bone Spine Rev. Rhum., 79, 370, 10.1016/j.jbspin.2011.06.010 Rahman, 2006, Association between the interleukin-1 family gene cluster and psoriatic arthritis, Arthritis Rheum., 54, 2321, 10.1002/art.21928 Stock, 2008, Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis, Genes Immun., 9, 349, 10.1038/gene.2008.24 Dehghan, 2011, Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels, Circulation, 123, 731, 10.1161/CIRCULATIONAHA.110.948570 Soto López, 2013, The interleukin-1 gene cluster polymorphisms are associated with Takayasu’s arteritis in Mexican patients, J. Interferon Cytokine Res., 33, 369, 10.1089/jir.2012.0126 Herder, 2014, Genetic determinants of circulating interleukin-1 receptor antagonist levels and their association with glycemic traits, Diabetes, 63, 4343, 10.2337/db14-0731 van de Veerdonk, 2012, IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist, Proc. Natl. Acad. Sci. U. S. A., 109, 3001, 10.1073/pnas.1121534109 Rudloff, 2015, Brief report interleukin-38 exerts antiinflammatory functions and is associated with disease activity in systemic lupus erythematosus, Arthritis Rheumatol. (Hoboken, NJ), 67, 3219, 10.1002/art.39328 Mora, 2016, Interleukin-38 is released from apoptotic cells to limit inflammatory macrophage responses, J. Mol. Cell Biol., 8, 426, 10.1093/jmcb/mjw006 Boutet, 2017, IL-38 overexpression induces anti-inflammatory effects in mice arthritis models and in human macrophages in vitro, Ann. Rheum. Dis., 76, 1304, 10.1136/annrheumdis-2016-210630 Jha, 2011, Chlamydia pneumoniae heat shock protein 60 is associated with apoptotic signaling pathway in human atheromatous plaques of coronary artery disease patients, J. Cardiol., 58, 216, 10.1016/j.jjcc.2011.07.010 Ciccia, 2015, Interleukin-36α axis is modulated in patients with primary Sjögren’s syndrome, Clin. Exp. Immunol., 181, 230, 10.1111/cei.12644 Zhao, 2015, Expression profile of IL-1 family cytokines in aqueous humor and sera of patients with HLA-B27 associated anterior uveitis and idiopathic anterior uveitis, Exp. Eye Res., 138, 80, 10.1016/j.exer.2015.06.018 Zhong, 2015, Elevated plasma IL-38 concentrations in patients with acute ST-segment elevation myocardial infarction and their dynamics after reperfusion treatment, Mediators Inflamm., 2015, 490120, 10.1155/2015/490120 Boutet, 2016, Distinct expression of interleukin (IL)-36α, β and γ, their antagonist IL-36Ra and IL-38 in psoriasis, rheumatoid arthritis and Crohn’s disease, Clin. Exp. Immunol., 184, 159, 10.1111/cei.12761 Yuan, 2016, IL-38 alleviates concanavalin A-induced liver injury in mice, Int. Immunopharmacol., 40, 452, 10.1016/j.intimp.2016.09.023 Wang, 2016, Elevated serum interleukin-38 level at baseline predicts virological response in telbivudine-treated patients with chronic hepatitis B, World J. Gastroenterol., 22, 4529, 10.3748/wjg.v22.i18.4529 Chu, 2016, Aberrant expression of novel cytokine IL-38 and regulatory T lymphocytes in childhood asthma, Molecules (Basel, Switz.), 21 Kim, 2016, Up-regulation of receptor antagonist interleukin-1 family members in psoriasis and their regulation by pro-inflammatory cytokines, J. Dermatol. Sci., 82, 204, 10.1016/j.jdermsci.2016.02.003 Wang, 2016, Detection of the novel IL-1 family cytokines by QAH-IL1F-1 assay in rheumatoid arthritis, Cell. Mol. Biol. (Noisy–Gd., Fr.), 62, 31 Zhang, 2017, The effect of interleukin 38 on angiogenesis in a model of oxygen-induced retinopathy, Sci. Rep., 7, 2756, 10.1038/s41598-017-03079-z Li, 2017, New interleukins in psoriasis and psoriatic arthritis patients: the possible roles of interleukin-33 to interleukin-38 in disease activities and bone erosions, Dermatology (Basel, Switz.), 233, 37, 10.1159/000471798 Chu, 2017, In vivo anti-inflammatory activities of novel cytokine IL-38 in Murphy Roths Large (MRL)/lpr mice, Immunobiology, 222, 483, 10.1016/j.imbio.2016.10.012 Tominaga, 2017, Overexpression of IL-38 protein in anticancer drug-induced lung injury and acute exacerbation of idiopathic pulmonary fibrosis, Respir. Investig., 55, 293, 10.1016/j.resinv.2017.06.001 Takada, 2017, Clinical implications of the novel cytokine IL-38 expressed in lung adenocarcinoma: possible association with PD-L1 expression, PLoS One, 12, 10.1371/journal.pone.0181598 Sabater-Lleal, 2013, Multiethnic meta-analysis of genome-wide association studies in >100 000 subjects identifies 23 fibrinogen-associated loci but no strong evidence of a causal association between circulating fibrinogen and cardiovascular disease, Circulation, 128, 1310, 10.1161/CIRCULATIONAHA.113.002251 Hessam, 2017, IL-36 in hidradenitis suppurativa: evidence for a distinctive pro-inflammatory role and a key factor in the development of an inflammatory loop, Br. J. Dermatol. Yu, 2017, IL-37 and 38 signalling in gestational diabetes, J. Reprod. Immunol., 124, 8, 10.1016/j.jri.2017.09.011 Afonina, 2015, Proteolytic processing of interleukin-1 family cytokines: variations on a common theme, Immunity, 42, 991, 10.1016/j.immuni.2015.06.003 Clancy, 2017, Neutrophil extracellular traps can serve as platforms for processing and activation of IL-1 family cytokines, FEBS J., 284, 1712, 10.1111/febs.14075 Towne, 2011, Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36α, IL-36β, and IL-36γ) or antagonist (IL-36Ra) activity, J. Biol. Chem., 286, 42594, 10.1074/jbc.M111.267922 Ainscough, 2017, Cathepsin S is the major activator of the psoriasis-associated proinflammatory cytokine IL-36γ, Proc. Natl. Acad. Sci., 114, E2748, 10.1073/pnas.1620954114 Aoyagi, 2017, IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia, Mucosal Immunol., 10, 1043, 10.1038/mi.2016.107 Ellisdon, 2017, Homodimerization attenuates the anti-inflammatory activity of interleukin-37, Sci. Immunol., 2, 10.1126/sciimmunol.aaj1548 Nold, 2010, IL-37 is a fundamental inhibitor of innate immunity, Nat. Immunol., 11, 1014, 10.1038/ni.1944 Garlanda, 2013, The interleukin-1 family: back to the future, Immunity, 39, 1003, 10.1016/j.immuni.2013.11.010 Bulau, 2014, Role of caspase-1 in nuclear translocation of IL-37, release of the cytokine, and IL-37 inhibition of innate immune responses, Proc. Natl. Acad. Sci. U. S. A., 111, 2650, 10.1073/pnas.1324140111 Yuan, 2016, Production of recombinant human interleukin-38 and its inhibitory effect on the expression of proinflammatory cytokines in THP-1 cells, Mol. Biol. (Mosk.), 50, 466, 10.1134/S0026893316030134 Lopez-Castejon, 2011, Understanding the mechanism of IL-1β secretion, Cytokine Growth Factor Rev., 22, 189, 10.1016/j.cytogfr.2011.10.001 Jiang, 2017, Dendritic cells should not be overlooked when studying the effect of IL-38 administration in arthritis, Ann. Rheum. Dis. Boutet, 2017, Response to: “Does IL-38 act on macrophages and/or dendritic cells in arthritis?” by Jiang, et al, Ann. Rheum. Dis. Gabay, 2015, Regulation and function of interleukin-36 cytokines in homeostasis and pathological conditions, J. Leukoc. Biol., 97, 645, 10.1189/jlb.3RI1014-495R Hahn, 2017, The novel interleukin-1 cytokine family members in inflammatory diseases, Curr. Opin. Rheumatol., 29, 208, 10.1097/BOR.0000000000000361 Shaik, 2013, IL-36 receptor antagonist with special emphasis on IL-38, Int. J. Immunopathol. Pharmacol., 26, 27, 10.1177/039463201302600103 van de Veerdonk, 2013, New insights in the immunobiology of IL-1 family members, Front. Immunol., 4, 167, 10.3389/fimmu.2013.00167 Hu, 2015, Expression, purification of IL-38 in Escherichia coli and production of polyclonal antibodies, Protein Expr. Purif., 107, 76, 10.1016/j.pep.2014.10.016 Tortola, 2012, Psoriasiform dermatitis is driven by IL-36–mediated DC-keratinocyte crosstalk, J. Clin. Invest., 122, 3965, 10.1172/JCI63451 Dietrich, 2016, Interleukin-36 potently stimulates human M2 macrophages, Langerhans cells and keratinocytes to produce pro-inflammatory cytokines, Cytokine, 84, 88, 10.1016/j.cyto.2016.05.012 Mutamba, 2012, Expression of IL-1Rrp2 by human myelomonocytic cells is unique to DCs and facilitates DC maturation by IL-1F8 and IL-1F9, Eur. J. Immunol., 42, 607, 10.1002/eji.201142035 Vigne, 2011, IL-36R ligands are potent regulators of dendritic and T cells, Blood, 118, 5813, 10.1182/blood-2011-05-356873 Penha, 2016, IL-36 receptor is expressed by human blood and intestinal T lymphocytes and is dose–dependently activated via IL-36β and induces CD4+ lymphocyte proliferation, Cytokine, 85, 18, 10.1016/j.cyto.2016.05.023 Gresnigt, 2013, The IL-36 receptor pathway regulates Aspergillus fumigatus- induced Th1 and Th17 responses: immunity to infection, Eur. J. Immunol., 43, 416, 10.1002/eji.201242711 Vigne, 2012, IL-36 signaling amplifies Th1 responses by enhancing proliferation and Th1 polarization of naive CD4+ T cells, Blood, 120, 3478, 10.1182/blood-2012-06-439026 Chi, 2017, IL-36 signaling facilitates activation of the NLRP3 inflammasome and IL-23/IL-17 axis in renal inflammation and fibrosis, J. Am. Soc. Nephrol., 28, 2022, 10.1681/ASN.2016080840 Lamacchia, 2013, The severity of experimental arthritis is independent of IL-36 receptor signaling, Arthritis Res. Ther., 15, R38, 10.1186/ar4192 Derer, 2014, Blockade of IL-36 receptor signaling does not prevent from TNF-induced arthritis, PLoS One, 9, 10.1371/journal.pone.0101954 Boraschi, 2013, The interleukin-1 receptor family, Semin. Immunol., 25, 394, 10.1016/j.smim.2013.10.023 Born, 2000, Identification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation Of a new class of IL-1R-related proteins based on signaling, J. Biol. Chem., 275, 29946, 10.1074/jbc.M004077200 Piton, 2008, Mutations in the calcium-related gene IL1RAPL1 are associated with autism, Hum. Mol. Genet., 17, 3965, 10.1093/hmg/ddn300 Nawara, 2008, Novel mutation of IL1RAPL1 gene in a nonspecific X-linked mental retardation (MRX) family, Am. J. Med. Genet. A, 146A, 3167, 10.1002/ajmg.a.32613 Laino, 2016, Clinical and molecular characterization of a boy with intellectual disability, facial dysmorphism, minor digital anomalies and a complex IL1RAPL1 intragenic rearrangement, Eur. J. Paediatr. Neurol., 20, 971, 10.1016/j.ejpn.2016.07.003 Ramos-Brossier, 2015, Novel IL1RAPL1 mutations associated with intellectual disability impair synaptogenesis, Hum. Mol. Genet., 24, 1106, 10.1093/hmg/ddu523 Yoshida, 2011, IL-1 receptor accessory protein-like 1 associated with mental retardation and autism mediates synapse formation by trans-synaptic interaction with protein tyrosine phosphatase, J. Neurosci., 31, 13485, 10.1523/JNEUROSCI.2136-11.2011 Yasumura, 2015, IL1RAPL1 knockout mice show spine density decrease, learning deficiency, hyperactivity and reduced anxiety-like behaviours, Sci. Rep., 4, 10.1038/srep06613 Pavlowsky, 2010, Neuronal JNK pathway activation by IL-1 is mediated through IL1RAPL1, a protein required for development of cognitive functions, Commun. Integr. Biol., 3, 245, 10.4161/cib.3.3.11414 Gambino, 2007, IL1-receptor accessory protein-like 1 (IL1RAPL1), a protein involved in cognitive functions, regulates N-type Ca2+-channel and neurite elongation, Proc. Natl. Acad. Sci., 104, 9063, 10.1073/pnas.0701133104 Khan, 2004, Crystal structure of the Toll/interleukin-1 receptor domain of human IL-1RAPL, J. Biol. Chem., 279, 31664, 10.1074/jbc.M403434200 Hayashi, 2013, IL1RAPL1 associated with mental retardation and autism regulates the formation and stabilization of glutamatergic synapses of cortical neurons through RhoA signaling pathway, PLoS One, 8, 10.1371/journal.pone.0066254 Marques, 2017, Suggestive association between variants in IL1RAPL and asthma symptoms in Latin American children, Eur. J. Hum. Genet., 25, 439, 10.1038/ejhg.2016.197 Molgora, 2016, Regulatory role of IL-1R8 in immunity and disease, Front. Immunol., 7, 10.3389/fimmu.2016.00149 Costelloe, 2008, IL-1F5 mediates anti-inflammatory activity in the brain through induction of IL-4 following interaction with SIGIRR/TIR8, J. Neurochem., 105, 1960, 10.1111/j.1471-4159.2008.05304.x Zhao, 2017, Interleukin 37 promotes angiogenesis through TGF-β signaling, Sci. Rep., 7, 6113, 10.1038/s41598-017-06124-z Keermann, 2015, Expression of IL-36 family cytokines and IL-37 but not IL-38 is altered in psoriatic skin, J. Dermatol. Sci., 80, 150, 10.1016/j.jdermsci.2015.08.002 Fullerton, 2016, Resolution of inflammation: a new therapeutic frontier, Nat. Rev. Drug Discov., 15, 551, 10.1038/nrd.2016.39 Hong, 2000, The inhibitory effect of interleukin-10 on mouse osteoclast formation involves novel tyrosine-phosphorylated proteins, J. Bone Miner., 15, 911, 10.1359/jbmr.2000.15.5.911 Song, 2017, Role of interleukin (IL)-17 and T-helper (Th)17 cells in cancer, Biochem. Biophys. Res. Commun., 493, 1, 10.1016/j.bbrc.2017.08.109 Robak, 2013, Correlations between concentrations of interleukin (IL)-17A, IL-17 B and IL-17F, and endothelial cells and proangiogenic cytokines in systemic lupus erythematosus patients, Eur. Cytokine Netw., 24, 60, 10.1684/ecn.2013.0330 Singh, 2013, Involvement of IL-9 in Th17-associated inflammation and angiogenesis of psoriasis, PLoS One, 8 Coxon, 2002, Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis, Arthritis Rheum., 46, 2604, 10.1002/art.10546 Celis, 2012, Synovial cytokine expression in psoriatic arthritis and associations with lymphoid neogenesis and clinical features, Arthritis Res. Ther., 14, R93, 10.1186/ar3817 van Baarsen, 2014, Heterogeneous expression pattern of interleukin 17A (IL-17A), IL-17F and their receptors in synovium of rheumatoid arthritis, psoriatic arthritis and osteoarthritis: possible explanation for nonresponse to anti-IL-17 therapy?, Arthritis Res. Ther., 16, 426, 10.1186/s13075-014-0426-z Miossec, 2017, Update on interleukin-17: a role in the pathogenesis of inflammatory arthritis and implication for clinical practice, RMD Open, 3, 10.1136/rmdopen-2016-000284 Carrier, 2011, Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis, J. Invest. Dermatol., 131, 2428, 10.1038/jid.2011.234 Kotake, 2017, The plasticity of Th17 cells in the pathogenesis of rheumatoid arthritis, J. Clin. Med., 6, 67, 10.3390/jcm6070067 Jones, 2017, Advances in rheumatoid arthritis, Med. J. Aust., 206, 221, 10.5694/mja16.01287 McInnes, 2015, Cytokines in rheumatoid arthritis – shaping the immunological landscape, Nat. Rev. Rheumatol., 12, 63, 10.1038/nrrheum.2015.171 McInnes, 2017, Pathogenetic insights from the treatment of rheumatoid arthritis, Lancet (Lond., Engl.), 389, 2328, 10.1016/S0140-6736(17)31472-1 Rossi-Semerano, 2013, First clinical description of an infant with interleukin-36-receptor antagonist deficiency successfully treated with anakinra, Pediatrics, 132, e1043, 10.1542/peds.2012-3935 Ummarino, 2017, Experimental arthritis: IL-38 promotes anti-inflammatory effects, Nat. Rev. Rheumatol., 13, 260, 10.1038/nrrheum.2017.55